CD81 and acute lymphoblastic leukemia: In the discovery phase, we extracted plasma exosomes from five patients with B-ALL and five healthy volunteers by ultracentrifugation; the plasma exosomes were then identified by transmission electron microscopy and nanoparticle tracking analysis, and specific antibodies were used to detect TSG101 and CD81 by western blot.